Latham & Watkins LLP represented Angion in the offering and private placement.Angion Biomedica Corp. (NASDAQ:ANGN) has announced the pricing of its initial public offering of 5 million…
Angion Biomedica’s Initial Public Offering and Concurrent Private Placement
![](https://globallegalchronicle.com/wp-content/uploads/2021/02/angion-biomedicas-initial-public-offering-and-concurrent-private-placement_602645501c657.jpeg)